Medical News / From ASRS 2021 - Anti-VEGF Continuation Wanes After 3-6 Years for Patients with nAMD

Theodore Leng, MD, MS, discusses new findings based on IRIS registry data showing long-term discontinuation trends in patients. Source: MDMag To view the third party content, kindly click on the link below or read more. You will then leave this site and enter a third party site.

read more

MORE MEDICAL NEWS
Real-world registry data presented this weekend at the American Society of Retina Specialists (ASRS) 2021 Scientific ... read more
The design of the American Society of Retina Specialists (ASRS) 2021 Scientific Meeting came to represent ... read more
Approximately 15 years into the era of anti-VEGF therapies for the treatment of age-related macular degeneration ... read more
In the coming weeks, the US Food and Drug Administration (FDA) will be considering the application ... read more